Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341859 · ClinicalTrials.gov registry record · NA
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02341859 is a NA study that has completed, run by CooperVision. The registered enrollment target is 22 participants.
The verdict
NCT02341859, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Lens Fitting Evaluation of CooperVision MyDay™ Compared with 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
Interventions
- DEVICE delefilcon A
- DEVICE stenfilcon A
- DEVICE narafilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02341859
The ClinicalTrials.gov registry entry for NCT02341859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which delefilcon A is the first listed.
NCT02341859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02341859 about?
NCT02341859 is a clinical study titled "Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®". Lens Fitting Evaluation of CooperVision MyDay™ Compared with 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
What is the current status of trial NCT02341859?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02341859?
The interventions under investigation include: delefilcon A (DEVICE), stenfilcon A (DEVICE), narafilcon A (DEVICE).
Who is sponsoring clinical trial NCT02341859?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.